David Lugo Palacios
@dlugopal
Followers
663
Following
2K
Media
28
Statuses
469
Assistant Prof in Health Economics @LSHTM_GHECO BA Econ @ITAM_mx | MSc Health Econ @bse_barcelona | PhD Health Econ @LSHTM @Chivas de corazón! 🇲🇽
London, United Kingdom
Joined September 2014
Muchas gracias @iacs_aragon por la invitación a las #JornadasRedETS2024! Gran evento con mesas súper interesantes!! Espero volver pronto a Zaragoza!!
“La innovación digital ha permitido la generación, colección y almacenamiento de un gran volumen de datos relacionados con la salud que nos dan información del paciente” David Lugo Palacios @dlugopal. Profesor Asistente. The London School of Hygiene and Tropical Medicine
1
1
10
Join us tomorrow for @MattXSutton's seminar! If you are in London, seminar is @LSHTM's Manson Lecture theatre. All welcome!
Join the next GHECO seminar with Professor Matt Sutton. The session will explore the use of supply-demand interactions to estimate effects of population health interventions. 🗓️ Wednesday 2 October 2024 🕐 13:00 BST ▶️ https://t.co/W5N9vqAA9m
1
4
15
3) Previous target trial emulations have assumed no unobserved confounding. While we found that this is a plausible assumption amongst the RCT-eligible subpopulation, our results suggest that this assumption is likely implausible for the RCT-ineligible subpopulation
0
0
0
Our 3 main contributions: 1) Our suggested approach accounts for essential heterogeneity for transporting results from RCT-eligigible populations to target populations relevant to the decision context
1
0
0
New @LSHTM_GHECO + @Basucally + @DrAmandaAdler + @karlado paper on @HECJournalTweet! We used target trial emulation with local #IVs to examine treatment effect heterogeneity across subpopulations eligible and ineligible for a published RCT https://t.co/udjoOURUfz
1
7
36
Our research showing how #IV methods can help inform clinical practice @pbidulka @CarrollOrlagh @Basucally @DrAmandaAdler @kamleshkhunti @SONeill1999 @RJ_Silverwood @TheStatsGeek @LiamSmeeth1
This research in @bmj_latest compared the effectiveness of three antidiabetic drugs for people with type 2 #diabetes mellitus. SGLT-2 inhibitors were more effective second line treatments compared with DPP-4 inhibitors or sulfonylureas, @pbidulka
https://t.co/hl5dfHPWxh
0
4
9
New @LSHTM_GHECO paper on @bmj_latest ! We assessed the comparative effectiveness of 3 second line antidiabetics by emulating a target trial with #IVs and electronic health records https://t.co/GT4AGbXBjF
1
3
29
Muy agradecido por la invitación de la @EGobiernoyTP para presentar un trabajo con colegas de @LSHTM_GHECO utilizando #targettrials y #LocalIV para estimar efectos de tratamiento heterogéneos
Hoy, @dlugopal, de @LSHTM, presentó estudio que muestra cómo los métodos de variable instrumental local (VIL) pueden proporcionar evidencia útil sobre la heterogeneidad del efecto de tratamientos médicos, incluyendo variables no observables. #FormamosElFuturo
2
1
5
There are two vacancies in our team for health economists/data scientists/statisticians! Join us!! @LSHTM_GHECO
https://t.co/3E5eAyACqo
jobs.lshtm.ac.uk
📢 @LSHTM is hiring two Research Fellows in #HealthEconomics/medical statistics/data science. Join our vibrant team, working with leading health economists, clinicians & statisticians, to advance quants methods & answer major policy questions. 5 Feb ⏰ https://t.co/R06KkI7xjt
0
6
17
He's coming home!! 🐐 #HO14CHICHARITO @Chivas
Always classy, Sir Alex 🫶 A heartfelt message for @CH14_ ahead of his return to his hometown club @Chivas 🇲🇽 #MUFC || #HO14CHICHARITO
0
0
2
It's my very big pleasure to share the fantastic news that @lkovacevic1 has successfully passed her PhD viva earlier today! Congrats Dr Kovacevic! Massive thanks to @HealthEcon_Will and Brendan Delaney for examining and facilitating a really interesting discussion!!
4
1
18
Thank you @HealthEcon_WMS for the invitation and a really interesting discussion!
Huge thank you to @dlugopal for delivering a great seminar to the CHEW team last week, titled "An approach for emulating RCTs to generate comparative effectiveness for decision-making" - a hugely interesting topic with a lot of potential!
0
0
5
Muy agradecido con @saludpublicaac por la invitación para participar en este panel. Se va a poner bueno! #somossaludpublica
1
1
10
Extremely proud of @lkovacevic1 as the first paper from her PhD has just been published! With @MOSSIALOS and colleagues from @Imperial_IGHI
Excited to share the first publication from my PhD is out in Health Policy - a systematic review on the impact of collaborative models and general practice size on safety and quality of care. with R. Naik, @dlugopal, H. Ashrafian, @MOSSIALOS and A. Darzi https://t.co/8BI2qITrYc
0
0
11
📡🗓️The next #LHEG meeting will be hosted by us at @imperialchepi & @ImperialBiz on Thursday, 2 November (5-7.15 pm). We will have three fantastic speakers: Prof @kdhauck (@Imperial_Jameel), Dr @goncalv_judite (@ImperialSPH) and Dr @dlugopal (@LSHTM_GHECO). More details👇👇
1
4
15
Great to know that our paper was included in Anaesthesia's Top 10 papers of 2022! @LSHTM_GHECO
As announced by @STHJournalClub at @Assoc_Anaes #AC2023, here are our best papers from 2022! 10 Right ventricular dysfunction in patients with COVID-19 pneumonitis whose lungs are mechanically ventilated👇 https://t.co/aBezdTypDm 9 A prospective observational study of the
0
0
8
Come and join our team @LSHTM @LSHTM_GHECO! One more week to apply! Deadline: 10th September
#VACANCY Research Fellow in Epi/MedStats/HealthEcon to assess #inequalities, comparative #effectiveness and cost-effectiveness of treatments for 3 major types of cancer Working with me and colleagues from @LSHTM_GHECO & @icon_lshtm
https://t.co/o2molq7QgF Deadline: 3 Sept
0
3
4
New month, new job? 👀 Join @LSHTM as a Research Fellow & assess inequalities, effectiveness & cost-effectiveness of treatments for 3 major types of cancer. Working with @dlugopal & @icon_lshtm 🤝 ➡️ https://t.co/cofmbk4tNi 📷 @theNCI
0
4
5